{"transactions":[{"id":701003,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2026-07-30T21:29:11.000Z","date":"2026-07-29","kind":"exercise","planned":true,"acquired":false,"shares":842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vested in 12 monthly installments beginning June 22, 2024."}],"balance_after":2140,"derivative":{"exercise_price":139.43,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":842},"source":{"system":"sec-edgar","filing":"0001533568-26-000012","document":"wk-form4_1785446949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000012/wk-form4_1785446949.xml","form_type":"4"}},{"id":701002,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-30T21:29:11.000Z","date":"2026-07-29","kind":"exercise","planned":true,"acquired":true,"shares":842,"price":139.43,"value":117400.06,"ownership":{"direct":true},"balance_after":2430,"source":{"system":"sec-edgar","filing":"0001533568-26-000012","document":"wk-form4_1785446949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000012/wk-form4_1785446949.xml","form_type":"4"}},{"id":701001,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-30T21:29:11.000Z","date":"2026-07-28","kind":"sale","planned":true,"acquired":false,"shares":1250,"price":182.006,"value":227507.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted and effective on September 15, 2025. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $182.00 to $182.03.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1588,"source":{"system":"sec-edgar","filing":"0001533568-26-000012","document":"wk-form4_1785446949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000012/wk-form4_1785446949.xml","form_type":"4"}},{"id":725277,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T20:23:00.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":22714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option award was granted on June 24, 2026. The shares underlying the award shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant, subject to the reporting person's continued service with the Issuer on the vesting date."}],"balance_after":22714,"derivative":{"exercise_price":8.05,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":22714},"source":{"system":"sec-edgar","filing":"0001628280-26-045787","document":"wk-form4_1782505378.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000162828026045787/wk-form4_1782505378.xml","form_type":"4"}},{"id":725276,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-26T20:23:00.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":15527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on June 24, 2026 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of (i) June 24, 2027 or (ii) immediately prior to the first annual meeting of stockholders occurring after the date of grant,  subject to the reporting person's continued service with the Issuer on the vesting date."}],"balance_after":41572,"source":{"system":"sec-edgar","filing":"0001628280-26-045787","document":"wk-form4_1782505378.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000162828026045787/wk-form4_1782505378.xml","form_type":"4"}},{"id":746934,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T22:07:54.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1250,"price":168.0573,"value":210071.625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted and effective on September 15, 2025. Additionally, Issuer policy\nrestricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $168.00 to $168.2550.  The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2838,"source":{"system":"sec-edgar","filing":"0001533568-26-000009","document":"wk-form4_1780956471.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000009/wk-form4_1780956471.xml","form_type":"4"}},{"id":759315,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2026-05-29T22:01:33.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 12 monthly installments beginning June 27, 2026."}],"balance_after":2624,"derivative":{"exercise_price":155.83,"expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":2624},"source":{"system":"sec-edgar","filing":"0001533568-26-000007","document":"wk-form4_1780092090.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000007/wk-form4_1780092090.xml","form_type":"4"}},{"id":759314,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restriced Stock Unit","published_at":"2026-05-29T22:01:33.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":1284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."}],"balance_after":1284,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1284},"source":{"system":"sec-edgar","filing":"0001533568-26-000007","document":"wk-form4_1780092090.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000007/wk-form4_1780092090.xml","form_type":"4"}},{"id":768851,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T23:22:18.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":1659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1659},"source":{"system":"sec-edgar","filing":"0001533568-26-000005","document":"wk-form4_1779405735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000005/wk-form4_1779405735.xml","form_type":"4"}},{"id":768850,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T23:22:18.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":1659,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4088,"source":{"system":"sec-edgar","filing":"0001533568-26-000005","document":"wk-form4_1779405735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000005/wk-form4_1779405735.xml","form_type":"4"}},{"id":309654,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-15T21:12:49.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":1447,"price":97.15,"value":140576.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":7376,"source":{"system":"sec-edgar","filing":"0000064803-26-000070","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000070/form4.xml","form_type":"4"}},{"id":779837,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T20:45:13.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":3810,"price":155.0134,"value":590601.054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted and effective on September 15, 2025.  Additionally,\nIssuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.00 to $155.0550. The Reporting Person has provided to the issuer, and\nwill provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2429,"source":{"system":"sec-edgar","filing":"0001533568-26-000003","document":"wk-form4_1778791511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356826000003/wk-form4_1778791511.xml","form_type":"4"}},{"id":932093,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2026-01-23T22:12:35.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 21, 2026, and will vest on January 1, 2027."}],"balance_after":15000,"derivative":{"exercise_price":94.15,"expiration_date":"2036-01-21","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193125-26-021266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526021266/ownership.xml","form_type":"4"}},{"id":940867,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-12T22:36:21.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":101.1,"value":202200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effectuated pursuant to a Rule 10b5-1 trading plan dated September 12, 2025 executed by the reporting person."}],"balance_after":10419,"source":{"system":"sec-edgar","filing":"0001193125-26-010697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312526010697/ownership.xml","form_type":"4"}},{"id":965987,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on May 18, 2022 and vested in 12 equal monthly installments beginning June 18, 2022."}],"balance_after":0,"derivative":{"exercise_price":84.95,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":965986,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":false,"shares":8276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on May 19, 2021 and vested in 12 equal monthly installments beginning June 19, 2021."}],"balance_after":557,"derivative":{"exercise_price":92.35,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":8276},"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":965985,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":1190,"price":155.0911,"value":184558.409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.09 to $155.40.  The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":6239,"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":965984,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-15","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":152.2287,"value":761143.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Additionally, Issuer\npolicy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.82. The Reporting Person has provided to the issuer, and will\nprovide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7429,"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":965983,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":1724,"price":84.95,"value":146453.8,"ownership":{"direct":true},"balance_after":12429,"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":965982,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-17T21:24:08.000Z","date":"2025-12-15","kind":"exercise","planned":true,"acquired":true,"shares":8276,"price":92.35,"value":764288.6,"ownership":{"direct":true},"balance_after":10705,"source":{"system":"sec-edgar","filing":"0001533568-25-000007","document":"wk-form4_1766006643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000153356825000007/wk-form4_1766006643.xml","form_type":"4"}},{"id":967299,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-16T21:18:16.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":88.85,"value":355400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effectuated pursuant to a Rule 10b5-1 Trading Plan dated September 12, 2025 executed by the reporting person."}],"balance_after":12419,"source":{"system":"sec-edgar","filing":"0001193125-25-320898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000119312525320898/ownership.xml","form_type":"4"}},{"id":316815,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-21T22:44:30.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":1652,"price":76.04,"value":125618.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":5929,"source":{"system":"sec-edgar","filing":"0000064803-25-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000006480325000064/form4.xml","form_type":"4"}},{"id":1099926,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-28T01:07:16.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":23105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date."}],"balance_after":23105,"derivative":{"exercise_price":7.8,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":23105},"source":{"system":"sec-edgar","filing":"0001655759-25-000112","document":"wk-form4_1751072831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575925000112/wk-form4_1751072831.xml","form_type":"4"}},{"id":1099925,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-28T01:07:16.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":16025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders,  subject to the reporting person's continued service with the Issuer on the vesting date."}],"balance_after":26045,"source":{"system":"sec-edgar","filing":"0001655759-25-000112","document":"wk-form4_1751072831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575925000112/wk-form4_1751072831.xml","form_type":"4"}},{"id":1138130,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:14:48.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1435},"source":{"system":"sec-edgar","filing":"0000914475-25-000126","document":"wk-form4_1747948480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000126/wk-form4_1747948480.xml","form_type":"4"}},{"id":1138129,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2025-05-22T21:14:48.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 12 monthly installments beginning June 21, 2025."}],"balance_after":3305,"derivative":{"exercise_price":120.56,"expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":3305},"source":{"system":"sec-edgar","filing":"0000914475-25-000126","document":"wk-form4_1747948480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000126/wk-form4_1747948480.xml","form_type":"4"}},{"id":1138128,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:14:48.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":1659,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."}],"balance_after":1659,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1659},"source":{"system":"sec-edgar","filing":"0000914475-25-000126","document":"wk-form4_1747948480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000126/wk-form4_1747948480.xml","form_type":"4"}},{"id":1138127,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:14:48.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2429,"source":{"system":"sec-edgar","filing":"0000914475-25-000126","document":"wk-form4_1747948480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000126/wk-form4_1747948480.xml","form_type":"4"}},{"id":322108,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-19T21:47:19.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":2077,"price":60.47,"value":125596.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan."}],"balance_after":4277,"source":{"system":"sec-edgar","filing":"0001127602-25-014957","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760225014957/form4.xml","form_type":"4"}},{"id":1188734,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2025-03-28T23:07:04.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 23, 2025, and will vest on January 1, 2026."}],"balance_after":15000,"derivative":{"exercise_price":92.42,"expiration_date":"2035-01-23","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-25-047041","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017025047041/ownership.xml","form_type":"4"}},{"id":329008,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-25T22:55:51.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":2200,"price":57.1,"value":125620.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001127602-24-028008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760224028008/form4.xml","form_type":"4"}},{"id":1454476,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-15T20:25:27.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":70,"value":70000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person."}],"balance_after":16419,"source":{"system":"sec-edgar","filing":"0000950170-24-083594","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024083594/ownership.xml","form_type":"4"}},{"id":1496364,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-31T21:50:43.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":9070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option award was granted on May 29, 2024. The shares underlying the award shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":9070,"derivative":{"exercise_price":33.9,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":9070},"source":{"system":"sec-edgar","filing":"0001655759-24-000081","document":"wk-form4_1717192234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575924000081/wk-form4_1717192234.xml","form_type":"4"}},{"id":1496363,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T21:50:43.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":5899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on May 29, 2024 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of May 29, 2025 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":10020,"source":{"system":"sec-edgar","filing":"0001655759-24-000081","document":"wk-form4_1717192234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575924000081/wk-form4_1717192234.xml","form_type":"4"}},{"id":1504407,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-05-23T22:02:27.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":2982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 12 monthly installments beginning June 22, 2024."}],"balance_after":2982,"derivative":{"exercise_price":139.43,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":2982},"source":{"system":"sec-edgar","filing":"0000914475-24-000144","document":"wk-form4_1716501731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000144/wk-form4_1716501731.xml","form_type":"4"}},{"id":1504406,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T22:02:27.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":1435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."}],"balance_after":1435,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1435},"source":{"system":"sec-edgar","filing":"0000914475-24-000144","document":"wk-form4_1716501731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000144/wk-form4_1716501731.xml","form_type":"4"}},{"id":1507784,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-21T21:06:21.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0000914475-24-000132","document":"wk-form4_1716325570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000132/wk-form4_1716325570.xml","form_type":"4"}},{"id":1507783,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T21:06:21.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":1106,"price":141.8173,"value":156849.9338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.81 to $142.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range"}],"balance_after":994,"source":{"system":"sec-edgar","filing":"0000914475-24-000132","document":"wk-form4_1716325570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000132/wk-form4_1716325570.xml","form_type":"4"}},{"id":1507782,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T21:06:21.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2100,"source":{"system":"sec-edgar","filing":"0000914475-24-000132","document":"wk-form4_1716325570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000132/wk-form4_1716325570.xml","form_type":"4"}},{"id":1568109,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-03-19T23:40:00.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":10590,"price":51.99,"value":550574.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan dated December 14, 2023 executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at a price range of $51.90 - $52.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) of this Form 4."}],"balance_after":17419,"source":{"system":"sec-edgar","filing":"0000950170-24-033817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024033817/ownership.xml","form_type":"4"}},{"id":1610884,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-02-29T23:50:29.000Z","date":"2024-02-27","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":84.95,"value":679600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests in 12 monthly installments beginning June 18, 2022."}],"balance_after":1724,"derivative":{"exercise_price":84.95,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000914475-24-000080","document":"wk-form4_1709250595.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000080/wk-form4_1709250595.xml","form_type":"4"}},{"id":1610883,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T23:50:29.000Z","date":"2024-02-27","kind":"sale","planned":true,"acquired":false,"shares":8000,"price":135.6735,"value":1085388.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $134.82 to $136.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000914475-24-000080","document":"wk-form4_1709250595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000080/wk-form4_1709250595.xml","form_type":"4"}},{"id":1610882,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-29T23:50:29.000Z","date":"2024-02-27","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":84.95,"value":679600.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000914475-24-000080","document":"wk-form4_1709250595.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000080/wk-form4_1709250595.xml","form_type":"4"}},{"id":1637842,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-16T16:35:44.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":2658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares scheduled to fully vest on February 14, 2025."}],"balance_after":18830,"source":{"system":"sec-edgar","filing":"0001437749-24-004597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000143774924004597/rdgdoc.xml","form_type":"4"}},{"id":1666395,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2024-01-30T22:09:55.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on January 26, 2024, and will vest on January 1, 2025."}],"balance_after":15000,"derivative":{"exercise_price":53.75,"expiration_date":"2034-01-26","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-008957","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000095017024008957/ownership.xml","form_type":"4"}},{"id":1786866,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy Class A Common Stock)","published_at":"2023-09-06T20:50:11.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on September 1, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months."}],"balance_after":15000,"derivative":{"exercise_price":54.23,"expiration_date":"2033-09-01","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-048414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123048414/doc4.xml","form_type":"4"}},{"id":1786865,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-06T20:50:11.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":25688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time of the Merger, each NuVasive restricted stock unit award was accelerated, cancelled and converted automatically into the right to receive 0.75 shares of Class A Common Stock, and cash in lieu of fractional shares, in respect of each share of NuVasive common stock underlying such award."}],"balance_after":28009,"source":{"system":"sec-edgar","filing":"0001209191-23-048414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123048414/doc4.xml","form_type":"4"}},{"id":1786864,"issuer":{"id":3496,"kind":"organization","name":"GLOBUS MEDICAL INC","symbol":"GMED"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-09-06T20:50:11.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":2321,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, NuVasive, Inc. (\"NuVasive\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into NuVasive (the \"Merger\"), with NuVasive continuing as a wholly owned subsidiary of the Issuer. At the effective time of the Merger (the \"Effective Time\"), each share of common stock of NuVasive owned by the Reporting Person was automatically converted into 0.75 shares of Class A common stock of Issuer, par value $0.001 per share (\"Class A Common Stock\"), and cash in lieu of fractional shares."}],"balance_after":2321,"source":{"system":"sec-edgar","filing":"0001209191-23-048414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237831/000120919123048414/doc4.xml","form_type":"4"}},{"id":1789648,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789647,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789646,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789645,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789644,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789643,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2130},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789642,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2822},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789641,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2501},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789640,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3725},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789639,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represented a contingent right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit award became fully vested and was cancelled and converted automatically into the right to receive (without interest) the Merger Consideration in respect of each share of Issuer common stock underlying such award."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5960},"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1789638,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-09-05T16:55:04.000Z","date":"2023-09-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3095,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the \"Merger Agreement\"), by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), Merger Sub merged with and into the Issuer, with the Issuer continuing as a wholly owned subsidiary of Globus. At the effective time of the merger (the \"Effective Time\"), each share of the Issuer's common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) was cancelled and converted into the right to receive 0.75 shares of Class A common stock of Globus  (\"Globus Class A Common Stock\"), par value $0.001 per share (the \"Exchange Ratio\" and such shares, the \"Merger Consideration\"), and cash in lieu of fractional shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-048186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123048186/doc4.xml","form_type":"4"}},{"id":1848960,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T21:28:21.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option award was granted on June 15, 2023. The shares underlying the award shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":12787,"derivative":{"exercise_price":30.33,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12787},"source":{"system":"sec-edgar","filing":"0001655759-23-000066","document":"wk-form4_1687296490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575923000066/wk-form4_1687296490.xml","form_type":"4"}},{"id":1848959,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-20T21:28:21.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":4121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on June 15, 2023 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 15, 2024 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":4121,"source":{"system":"sec-edgar","filing":"0001655759-23-000066","document":"wk-form4_1687296490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000165575923000066/wk-form4_1687296490.xml","form_type":"4"}},{"id":1859240,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2023-06-12T17:56:09.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":4816,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2024 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 8, 2023, Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Globus Medical, Inc. (\"Globus Medical\") and Zebra Merger Sub, Inc. (\"Merger Sub\"), a wholly owned subsidiary of Globus Medical. The Merger Agreement provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Globus Medical. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each RSU outstanding immediately prior to the Effective Time held by the Reporting Person will fully vest and be cancelled and converted automatically into the right to receive (without interest) 0.75 fully paid and non-assessable shares of Class A common stock of Globus Medical (and cash in lieu of any fractional shares) in respect of each share of Issuer's common stock underlying such RSU."}],"balance_after":4816,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4816},"source":{"system":"sec-edgar","filing":"0001209191-23-036457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919123036457/doc4.xml","form_type":"4"}},{"id":1885692,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-19T21:19:56.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units will vest in full on May 17, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units will vest in full on May 17, 2024."}],"balance_after":2100,"derivative":{"underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001209191-23-031112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123031112/doc4.xml","form_type":"4"}},{"id":1885691,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2023-05-19T21:19:56.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 monthly installments beginning June 17, 2023."}],"balance_after":4290,"derivative":{"exercise_price":95.27,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":4290},"source":{"system":"sec-edgar","filing":"0001209191-23-031112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123031112/doc4.xml","form_type":"4"}},{"id":2003099,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-21T16:17:21.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":1314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted shares scheduled to fully vest on February 16, 2024."}],"balance_after":16172,"source":{"system":"sec-edgar","filing":"0001437749-23-003976","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000143774923003976/rdgdoc.xml","form_type":"4"}},{"id":2224987,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-22T00:00:14.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":10192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 16, 2022. The shares underlying the award shall vest in full on the earlier of June 16, 2023 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders."}],"balance_after":10192,"derivative":{"exercise_price":36.79,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":10192},"source":{"system":"sec-edgar","filing":"0001209191-22-038552","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000120919122038552/doc4.xml","form_type":"4"}},{"id":2249800,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-06-01T16:56:12.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":1547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 28, 2020. In accordance with the terms of the RSU award, the award vested as to 3,095 shares on May 18, 2021. Pursuant to deferral elections made by the Reporting Person, 1,548 of the shares underlying the RSUs were delivered on June 1, 2021 and 1,547 shares were delivered on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 28, 2020. In accordance with the terms of the RSU award, the award vested as to 3,095 shares on May 18, 2021. Pursuant to deferral elections made by the Reporting Person, 1,548 of the shares underlying the RSUs were delivered on June 1, 2021 and 1,547 shares were delivered on June 1, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1547},"source":{"system":"sec-edgar","filing":"0001209191-22-033199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122033199/doc4.xml","form_type":"4"}},{"id":2249799,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:56:12.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":1547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":3095,"source":{"system":"sec-edgar","filing":"0001209191-22-033199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122033199/doc4.xml","form_type":"4"}},{"id":2262526,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-05-20T20:09:36.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":9724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 monthly installments beginning June 18, 2022."}],"balance_after":9724,"derivative":{"exercise_price":84.95,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":9724},"source":{"system":"sec-edgar","filing":"0001209191-22-030979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122030979/doc4.xml","form_type":"4"}},{"id":2272336,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2022-05-13T17:59:18.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2023 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3788,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3788},"source":{"system":"sec-edgar","filing":"0001209191-22-028940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919122028940/doc4.xml","form_type":"4"}},{"id":2309203,"issuer":{"id":3133,"kind":"organization","name":"CENTENE CORP","symbol":"CNC"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T00:40:32.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":381.005,"price":82.02,"value":31250.0301,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Ownership includes 1,100 shares of restricted stock units subject to vesting requirements."}],"balance_after":1481.005,"source":{"system":"sec-edgar","filing":"0001071739-22-000147","document":"wf-form4_164911921050580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000147/wf-form4_164911921050580.xml","form_type":"4"}},{"id":2406855,"issuer":{"id":3133,"kind":"organization","name":"CENTENE CORP","symbol":"CNC"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Option (right to buy)","published_at":"2022-02-10T00:33:17.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in three equal installments on the anniversary of the grant beginning on February 7, 2023."}],"balance_after":10000,"derivative":{"exercise_price":80.57,"exercise_date":"2025-02-07","expiration_date":"2032-02-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001071739-22-000057","document":"wf-form4_164445317574798.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000057/wf-form4_164445317574798.xml","form_type":"4"}},{"id":2406854,"issuer":{"id":3133,"kind":"organization","name":"CENTENE CORP","symbol":"CNC"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-10T00:33:17.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":1100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Ownership includes 1,100 shares of restricted stock vesting on the date of the April 2022 Annual Meeting of Stockholders."}],"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001071739-22-000057","document":"wf-form4_164445317574798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173922000057/wf-form4_164445317574798.xml","form_type":"4"}},{"id":2406107,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-09T20:24:21.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":1223,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14858,"source":{"system":"sec-edgar","filing":"0001437749-22-002923","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000143774922002923/rdgdoc.xml","form_type":"4"}},{"id":2453270,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2022-01-04T17:20:25.000Z","date":"2022-01-04","kind":"disposition_to_issuer","acquired":false,"shares":5698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Includes 2,911 restricted shares of Common Stock.  In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 2,911 restricted shares of Common Stock.  In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 4, 2021 (the \"Merger Agreement\"), by and among the Issuer, Centene Corporation (\"Centene\") and Mayflower Merger Sub, Inc. (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a wholly owned subsidiary of Centene, each share of the Issuer's common stock, par value $0.01 per share (the \"Common Stock\") outstanding immediately prior to the effective time of the Merger and not otherwise excluded pursuant to the terms of the Merger Agreement was disposed of in exchange for $95.00 per share in cash, without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 2,911 restricted shares of Common Stock.  In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each of these restricted shares of Common Stock was automatically cancelled and converted into the right to receive the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-001002","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919122001002/doc4.xml","form_type":"4"}},{"id":2604870,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2021-08-13T16:41:07.000Z","date":"2021-08-13","kind":"grant","acquired":true,"shares":789,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One half of the annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the first anniversary of the grant date, subject to earlier acceleration or forfeiture."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":5698,"source":{"system":"sec-edgar","filing":"0001209191-21-051410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919121051410/doc4.xml","form_type":"4"}},{"id":2673446,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T00:00:43.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":7511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 8, 2021. The shares underlying the award shall vest in full on June 8, 2022 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":7511,"derivative":{"exercise_price":78.53,"expiration_date":"2021-06-07","underlying":"Common Stock","underlying_shares":7511},"source":{"system":"sec-edgar","filing":"0001209191-21-039677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000120919121039677/doc4.xml","form_type":"4"}},{"id":2683999,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-06-03T17:56:47.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":1548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 28, 2020. In accordance with the terms of the RSU award, the award vested as to 3,095 shares on May 18, 2021. Pursuant to deferral elections made by the Reporting Person, 1,548 of the shares underlying the RSUs were delivered on June 1, 2021 and 1,547 shares will be delivered on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 28, 2020. In accordance with the terms of the RSU award, the award vested as to 3,095 shares on May 18, 2021. Pursuant to deferral elections made by the Reporting Person, 1,548 of the shares underlying the RSUs were delivered on June 1, 2021 and 1,547 shares will be delivered on June 1, 2022."}],"balance_after":1547,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1548},"source":{"system":"sec-edgar","filing":"0001209191-21-037851","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121037851/doc4.xml","form_type":"4"}},{"id":2683998,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-03T17:56:47.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":1548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards."}],"balance_after":1548,"source":{"system":"sec-edgar","filing":"0001209191-21-037851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121037851/doc4.xml","form_type":"4"}},{"id":2703965,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2021-05-20T20:08:43.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":8833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 19, 2021."}],"balance_after":8833,"derivative":{"exercise_price":92.35,"exercise_date":"2021-06-19","expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":8833},"source":{"system":"sec-edgar","filing":"0001209191-21-034383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121034383/doc4.xml","form_type":"4"}},{"id":2703559,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2021-05-20T17:54:58.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":2702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2022 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2702,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2702},"source":{"system":"sec-edgar","filing":"0001209191-21-034555","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919121034555/doc4.xml","form_type":"4"}},{"id":2862733,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-12T17:11:44.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13635,"source":{"system":"sec-edgar","filing":"0001437749-21-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000143774921002837/rdgdoc.xml","form_type":"4"}},{"id":3104969,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2020-06-19T16:28:48.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":2122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2021 Annual Meeting of Shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":4909,"source":{"system":"sec-edgar","filing":"0001209191-20-037933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919120037933/doc4.xml","form_type":"4"}},{"id":3121656,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-05T01:00:11.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on June 3, 2020. The shares underlying the award shall vest in full on June 3, 2021 or, if earlier, the date of the first meeting of the board of directors of the Issuer held after the Issuer's next annual meeting of stockholders."}],"balance_after":12000,"derivative":{"exercise_price":33.57,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-034583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000120919120034583/doc4.xml","form_type":"4"}},{"id":3130883,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2020-05-29T17:56:00.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":3095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred as follows: 1,548 shares will be delivered on June 1, 2021 and 1,547 shares will be delivered on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred as follows: 1,548 shares will be delivered on June 1, 2021 and 1,547 shares will be delivered on June 1, 2022."}],"balance_after":3095,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3095},"source":{"system":"sec-edgar","filing":"0001209191-20-033006","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919120033006/doc4.xml","form_type":"4"}},{"id":3139709,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2020-05-21T22:57:06.000Z","date":"2020-05-19","kind":"grant","acquired":true,"shares":6018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 19, 2020."}],"balance_after":6018,"derivative":{"exercise_price":119.93,"exercise_date":"2020-06-19","expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":6018},"source":{"system":"sec-edgar","filing":"0001209191-20-031496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919120031496/doc4.xml","form_type":"4"}},{"id":3266440,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-18T16:03:31.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":1952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units scheduled to vest 100% on the first anniversary."}],"balance_after":12910,"source":{"system":"sec-edgar","filing":"0001437749-20-002902","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000143774920002902/rdgdoc.xml","form_type":"4"}},{"id":3416641,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2019-09-12T20:06:16.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted September 10, 2019 and vests in 36 equal monthly installments."}],"balance_after":15000,"derivative":{"exercise_price":95.18,"expiration_date":"2029-09-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-049291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919119049291/doc4.xml","form_type":"4"}},{"id":3445952,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase","published_at":"2019-08-06T17:16:59.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":9023,"price":6.67,"value":60183.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% of the option award shall vest on August 5, 2020."}],"balance_after":9023,"derivative":{"exercise_price":6.67,"exercise_date":"2020-08-05","expiration_date":"2029-08-05","underlying":"Common Stock","underlying_shares":9023},"source":{"system":"sec-edgar","filing":"0001013606-19-000136","document":"wf-form4_156512620096153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000136/wf-form4_156512620096153.xml","form_type":"4"}},{"id":3445951,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-06T17:16:59.000Z","date":"2019-08-05","kind":"grant","acquired":true,"shares":13494,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the time-based restricted stock unit award shall vest on August 5, 2020 and shall settle in shares of common stock."}],"balance_after":29932,"source":{"system":"sec-edgar","filing":"0001013606-19-000136","document":"wf-form4_156512620096153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000136/wf-form4_156512620096153.xml","form_type":"4"}},{"id":3455092,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-26T20:56:20.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":25846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was granted on July 24, 2019. The shares underlying the award shall vest in equal monthly installments through July 24, 2022."}],"balance_after":25846,"derivative":{"exercise_price":24.3,"expiration_date":"2029-07-23","underlying":"Common Stock","underlying_shares":25846},"source":{"system":"sec-edgar","filing":"0000899243-19-020450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533568/000089924319020450/doc4.xml","form_type":"4"}},{"id":3480857,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2019-06-24T19:39:31.000Z","date":"2019-06-21","kind":"grant","acquired":true,"shares":2251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2020 Annual Meeting of Shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":2787,"source":{"system":"sec-edgar","filing":"0001209191-19-038853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919119038853/doc4.xml","form_type":"4"}},{"id":3531800,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2019-05-10T17:58:58.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":2577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2577,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2577},"source":{"system":"sec-edgar","filing":"0001209191-19-029064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919119029064/doc4.xml","form_type":"4"}},{"id":3541781,"issuer":{"id":131790,"kind":"organization","name":"MAGELLAN HEALTH INC","symbol":"MGLN"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Common Stock, $0.01 par value","published_at":"2019-05-03T13:18:14.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pro-rated annual director restricted stock award pursuant to 2016 Management Incentive Plan. Shares shall vest fully on the date of the 2019 Annual Meeting of Shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":536,"source":{"system":"sec-edgar","filing":"0001209191-19-027199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/19411/000120919119027199/doc4.xml","form_type":"4"}},{"id":3649245,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:17:36.000Z","date":"2019-02-14","kind":"grant","acquired":true,"shares":1857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10958,"source":{"system":"sec-edgar","filing":"0001220754-19-000027","document":"wf-form4_155061464264226.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000122075419000027/wf-form4_155061464264226.xml","form_type":"4"}},{"id":3714697,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-02T20:05:28.000Z","date":"2018-12-30","kind":"grant","acquired":true,"shares":120887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"100% of the time-based restricted stock unit award shall vest on December 30, 2019 and shall settle in shares of common stock."}],"balance_after":164378,"source":{"system":"sec-edgar","filing":"0001013606-19-000016","document":"wf-form4_154647751238162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360619000016/wf-form4_154647751238162.xml","form_type":"4"}},{"id":3944442,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2018-05-07T18:07:36.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":3230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2019 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2019 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":3230,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3230},"source":{"system":"sec-edgar","filing":"0001209191-18-028417","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919118028417/doc4.xml","form_type":"4"}},{"id":4043774,"issuer":{"id":76927,"kind":"organization","name":"ModivCare Inc","symbol":"MODV"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-21T17:00:57.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":2017,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9101,"source":{"system":"sec-edgar","filing":"0001220754-18-000014","document":"wf-form4_151925044041879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1220754/000122075418000014/wf-form4_151925044041879.xml","form_type":"4"}},{"id":4296599,"issuer":{"id":146591,"kind":"organization","name":"ENDOLOGIX INC /DE/","symbol":"ELGX"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T12:23:28.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":22822,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43491,"source":{"system":"sec-edgar","filing":"0001013606-17-000083","document":"wf-form4_149642059226878.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013606/000101360617000083/wf-form4_149642059226878.xml","form_type":"4"}},{"id":4310205,"issuer":{"id":110002,"kind":"organization","name":"NUVASIVE INC","symbol":"NUVA"},"owners":[{"id":14658,"kind":"person","name":"Norwalk Leslie V","position":1,"cik":"0001533568","reported_name":"Norwalk Leslie V","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"RSUs","published_at":"2017-05-22T17:50:41.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":2130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2018 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2018 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors."}],"balance_after":2130,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2130},"source":{"system":"sec-edgar","filing":"0001209191-17-034405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1142596/000120919117034405/doc4.xml","form_type":"4"}}],"next_cursor":"2017-05-22T17:50:41.000000Z,4310205"}